Campylobacter source attribution by exposure assessment. International Journal of Risk Assessment Management
2008; 8: 174–190.
Water-borne Campylobacter jejuni infection in a Danish town – a 6-week continuous source outbreak. Clinical Microbiology and Infection
1998; 4: 648–656.
Kuusi, M, et al.
An outbreak of gastroenteritis from a non-chlorinated community water supply. Journal of Epidemiology and Community Health
2004; 58: 273–277.
Kuusi, M, et al.
A large outbreak of campylobacteriosis associated with a municipal water supply in Finland. Epidemiology and Infection
2005; 133: 593–601.
Martin, S, et al.
A case-cohort study to investigate concomitant waterborne outbreaks of Campylobacter and gastroenteritis in Söderhamn, Sweden, 2002–3. Journal of Water Health
2006; 4: 417–24.
Jakopanec, I, et al.
A large waterborne outbreak of campylobacteriosis in Norway: the need to focus on distribution system safety. BMC Infectious Diseases
2008; 8: 128.
Gubbels, SM, et al.
A waterborne outbreak with a single clone of Campylobacter jejuni in the Danish town of Køge in May 2010. Scandinavian Journal of Infectious Diseases
2012; 44: 586–594.
Hardnett, FP, et al.
Epidemiological issues in study design and data analysis related to FoodNet activities. Clinical Infectious Diseases
2004; 38: S121–126.
Ang, CW, et al.
Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clinical Microbiology and Infection
2007; 13: 915–922.
Tam, CC, et al.
Guillain-Barré syndrome and preceding infection with Campylobacter, influenza and Epstein–Barr virus in the general practice research database. PLoS ONE
2007; 2: e344.
Kuhn, KG, et al.
Detection of antibodies to Campylobacter in humans using enzyme-linked immunosorbent assays: a review of the literature. Diagnostic Microbiology and Infectious Diseases
2012; 74: 113–118.
Mortensen, NP, et al.
Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes and Infection
2009; 11: 988–994.
Strid, MA, et al.
Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clinical and Diagnostic Laboratory Immunology
2001; 8: 314–319.
Taylor, BV, et al.
Sensitivity and specificity of serology in determining recent acute Campylobacter infection. Internal Medicine Journal
2004; 34: 250–258.
Meinersmann, RJ, et al.
Discrimination of Campylobacter jejuni isolates by fla gene sequencing. Journal of Clinical Microbiology
1997; 35: 2810–2814.
Guzman-Herrador, B, et al.
Waterborne outbreaks in the Nordic countries, 1998 to 2012. Eurosurveillance
2015; 20: 1–10.
Simonsen, J, et al.
Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine
2009; 28: 1882–1895.
Mølbak, K, et al.
Seroincidence of human infections with nontyphoid Salmonella compared with data from public health surveillance and food animals in 13 European countries. Clinical Infectious Diseases
2014; 59: 1599–1606.
Serological cross-sectional studies on Salmonella incidence in eight European countries: no correlation with incidence of reported cases. BMC Public Health
2012; 16: 523.
Simonsen, J, et al.
Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiology and Infection
2008; 136: 895–902.
Teunis, PFM, et al.
Campylobacter seroconversion rates in selected countries in the European Union. Epidemiology and Infection
2013; 141: 2051–2057.
Emborg, HD, et al.
Was the increase in culture-confirmed Campylobacter infections in Denmark during the 1990s a surveillance artefact?
2015; 20: pii = 30041.